These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15061248)

  • 1. Clozapine's effects on body weight and resting metabolic rate: a case series.
    Procyshyn RM; Chau A; Tse G
    Schizophr Res; 2004 Feb; 66(2-3):159-62. PubMed ID: 15061248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A weight off the mind: Clozapine and profound weight loss.
    Webster A; Ingram L
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1212-3. PubMed ID: 23881075
    [No Abstract]   [Full Text] [Related]  

  • 3. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K; Tungaraza TE; Harborne GC
    J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
    Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
    J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classics in chemical neuroscience: clozapine.
    Wenthur CJ; Lindsley CW
    ACS Chem Neurosci; 2013 Jul; 4(7):1018-25. PubMed ID: 24047509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy.
    Wysokiński A; Kłoszewska I
    Psychiatry Res; 2014 Dec; 220(1-2):170-4. PubMed ID: 25219614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients.
    Miljevic C; Nikolic M; Nikolic-Kokic A; Jones DR; Niketic V; Lecic-Tosevski D; Spasic MB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):303-7. PubMed ID: 19962416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight.
    Hinze-Selch D; Deuschle M; Weber B; Heuser I; Pollmächer T
    Psychopharmacology (Berl); 2000 Apr; 149(2):163-9. PubMed ID: 10805611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
    Carpenter WT; Zito JM; Vitrai J; Volavka J
    Biol Psychiatry; 1998 Jan; 43(2):79-83. PubMed ID: 9474440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing treatment with clozapine.
    Conley RR
    J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine.
    Roy-Desruisseaux J; Grignon S
    Hum Psychopharmacol; 2010 Jul; 25(5):428. PubMed ID: 20589919
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process.
    Dickens D; Rädisch S; Chiduza GN; Giannoudis A; Cross MJ; Malik H; Schaeffeler E; Sison-Young RL; Wilkinson EL; Goldring CE; Schwab M; Pirmohamed M; Nies AT
    Mol Pharm; 2018 Aug; 15(8):3557-3572. PubMed ID: 29944835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine administration ameliorates disrupted long-range synchrony in a neurodevelopmental animal model of schizophrenia.
    Dickerson DD; Restieaux AM; Bilkey DK
    Schizophr Res; 2012 Mar; 135(1-3):112-5. PubMed ID: 22260963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication.
    Sharpe JK; Byrne NM; Stedman TJ; Hills AP
    J Am Diet Assoc; 2005 Apr; 105(4):612-5. PubMed ID: 15800566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.